NCT05050058

Brief Summary

The aim of this work was to:

  1. 1.Evaluate the use of echocardiography in the assessment of hemodynamic stability in newborns.
  2. 2.Determine the prevalence of congenital heart diseases or any cardiac abnormalities in infants born to diabetic mother in relation to the glycemic control of their mothers

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2021

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

September 10, 2021

Last Update Submit

November 25, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Detection of incidence of congenital heart disease in infants of diabetic mothers

    This was done using echocardiography: two-dimensional study, color Doppler, pulsed and continuous wave Doppler as well as m-mode study.

    First week

  • Hemodynamic significance of patent ductus arteriosus (PDA)and patent Foramen Ovale (PFO)

    This was done using echocardiography: two-dimensional study, color Doppler, pulsed and continuous wave Doppler as well as m-mode study for assessments of PDA and PFO in infants of diabetic mothers in comparison with healthy controls.

    First two months of life

  • Assessment of left ventricular dimensions in infants of diabetic mothers in comparison to healthy controls.

    Using M-mode images under guidance of two dimensional echocardiography in parasternal long axis view was done for all participants measuring of the following: * Left ventricular end systolic diameter (LVDs). * Left ventricular end diastolic diameter (LVDd). * Inter ventricular septal diameter (IVSd). * Left ventricular posterior wall thickness during diastole (LVPWd). * Left ventricular posterior wall thickness during systole (LVPWs) those measures are compared in infant of diabetic mothers and healthy controls.

    First two months of life

  • Assessment of left ventricular dimensions in infants of diabetic mothers in comparison to healthy controls.

    Using M-mode images under guidance of two dimensional echocardiography in parasternal long axis view was done for all participants measuring of the following: * Ejection fraction (EF) . * Fractional shortening (FS). those measures are compared in infant of diabetic mothers and healthy controls.

    First two months of life

Study Arms (2)

Neonates born to diabetic mothers

Neonates born to non-diabetic mothers (control)

Eligibility Criteria

Age0 Days - 7 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study was conducted on 50 neonates admitted to the neonatal intensive care unit in Alexandria University Children's Hospital. This study included two groups: Group Ι: Include 25 neonates born to diabetic mother Group II: Include 25 neonates born to non-diabetic mothers as a control group (reference group).

You may qualify if:

  • Infant of diabetic mother (IDM) (pregestational and gestational diabetes) born in Alexandria University Children 's Hospital (AUCH) whatever their weight or their gestational age

You may not qualify if:

  • Neonates aged more 7 days.
  • Patient born outside the tertiary center of Alexandria University Children 's Hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.

Alexandria, 21131, Egypt

Location

Related Publications (1)

  • Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, Lai WW, Geva T. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010 May;23(5):465-95; quiz 576-7. doi: 10.1016/j.echo.2010.03.019. No abstract available.

    PMID: 20451803BACKGROUND

Study Officials

  • Asmaa MR Emara, MBBCh

    Faculty of Medicine, Alexandria University, Egypt

    PRINCIPAL INVESTIGATOR
  • Iman M Marzouk, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY DIRECTOR
  • Aly M Abdel-Mohsen, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY DIRECTOR
  • Marwa M Farag, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer in Pediatrics, Faculty of Medicine

Study Record Dates

First Submitted

September 10, 2021

First Posted

September 20, 2021

Study Start

March 8, 2020

Primary Completion

June 12, 2021

Study Completion

June 20, 2021

Last Updated

November 30, 2022

Record last verified: 2022-11

Locations